David E Ambrose

6.5k total citations · 1 hit paper
10 papers, 1.4k citations indexed

About

David E Ambrose is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, David E Ambrose has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in David E Ambrose's work include CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Glioma Diagnosis and Treatment (2 papers). David E Ambrose is often cited by papers focused on CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Glioma Diagnosis and Treatment (2 papers). David E Ambrose collaborates with scholars based in United States. David E Ambrose's co-authors include Bruce L. Levine, Simon F. Lacey, Carl H. June, J. Joseph Melenhorst, Michael C. Milone, Noelle V. Frey, Stephan A. Grupp, Zhaohui Zheng, Wei‐Ting Hwang and Pamela A. Shaw and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

David E Ambrose

10 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

2015 1.3k citations David Porter, Wei‐Ting Hwang et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E Ambrose United States	6	1.3k	442	408	377	366	10	1.4k
Dayenne G. van Leeuwen United States	8	1.4k 1.1×	601 1.4×	502 1.2×	438 1.2×	444 1.2×	10	1.5k
Colette Chaney United States	13	1.3k 1.0×	733 1.7×	293 0.7×	380 1.0×	432 1.2×	19	1.7k
Brandon Ballard United States	10	847 0.7×	311 0.7×	226 0.6×	326 0.9×	259 0.7×	16	1.0k
Hannah Brakke United States	5	1.3k 1.0×	226 0.5×	387 0.9×	343 0.9×	393 1.1×	5	1.4k
Sang M. Nguyen United States	10	1.2k 1.0×	370 0.8×	437 1.1×	418 1.1×	376 1.0×	16	1.4k
Reona Sakemura United States	13	717 0.6×	261 0.6×	261 0.6×	249 0.7×	227 0.6×	54	879
Peihua Lu China	18	1.2k 0.9×	553 1.3×	229 0.6×	380 1.0×	356 1.0×	74	1.6k
Oumar Diouf United States	5	1.1k 0.9×	561 1.3×	260 0.6×	318 0.8×	371 1.0×	9	1.3k
Lingfeng Liu United States	11	1.3k 1.0×	451 1.0×	535 1.3×	489 1.3×	359 1.0×	12	1.4k
Corinne Summers United States	15	1.3k 1.0×	253 0.6×	343 0.8×	319 0.8×	411 1.1×	42	1.5k

Countries citing papers authored by David E Ambrose

Since Specialization

Citations

This map shows the geographic impact of David E Ambrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E Ambrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E Ambrose more than expected).

Fields of papers citing papers by David E Ambrose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E Ambrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E Ambrose. The network helps show where David E Ambrose may publish in the future.

Co-authorship network of co-authors of David E Ambrose

This figure shows the co-authorship network connecting the top 25 collaborators of David E Ambrose. A scholar is included among the top collaborators of David E Ambrose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E Ambrose. David E Ambrose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Reichenbach, Zachary Wilmer, David E Ambrose, William D. Cornwell, et al.. (2022). Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966. Frontiers in Pharmacology. 13. 803331–803331. 6 indexed citations

Cornwell, William D., Uma Sriram, Alecia Seliga, et al.. (2020). Tobacco smoke and morphine alter peripheral and CNS inflammation following HIV infection in a humanized mouse model. Scientific Reports. 10(1). 13977–13977. 5 indexed citations

Melenhorst, J. Joseph, David Porter, Lifeng Tian, et al.. (2018). Long-Term Remission of CLL Sustained By Pauciclonal Anti-CD19 Chimeric Antigen Receptor T (CTL019) Cell Clones. Blood. 132(Supplement 1). 699–699. 3 indexed citations

Orlando, Elena J., Rebecca Leary, Simon F. Lacey, et al.. (2017). Gene expression signatures of response to anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with CLL and ALL.. Journal of Clinical Oncology. 35(7_suppl). 137–137. 1 indexed citations

O’Rourke, Donald M., Fang Chen, Zev A. Binder, et al.. (2017). Abstract LB-053: Next-generation sequencing of T-cell receptor-beta gene rearrangements reveals dramatic expansion of T-cell clonotypes after CART-EGFRvIII therapy for glioblastoma. Cancer Research. 77(13_Supplement). LB–53. 1 indexed citations

Lacey, Simon F., Jun Xu, Marco Ruella, et al.. (2016). Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR. Blood. 128(22). 281–281. 14 indexed citations

Garfall, Alfred L., Eric Lancaster, Edward A. Stadtmauer, et al.. (2016). Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide. Blood. 128(22). 5702–5702. 36 indexed citations

Fraietta, Joseph A., Simon F. Lacey, Nicholas S. Wilcox, et al.. (2016). Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia. Blood. 128(22). 57–57. 15 indexed citations

Porter, David, Wei‐Ting Hwang, Noelle V. Frey, et al.. (2015). Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Science Translational Medicine. 7(303). 303ra139–303ra139. 1317 indexed citations breakdown →

10.

Kalos, Michael, Farzana Nazimuddin, Jeffrey Finklestein, et al.. (2013). Long-Term Functional Persistence, B Cell Aplasia and Anti-Leukemia Efficacy In Refractory B Cell Malignancies Following T Cell Immunotherapy Using CAR-Redirected T Cells Targeting CD19. Blood. 122(21). 163–163. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact